These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21675914)

  • 1. Managed competition for Medicare? Sobering lessons from The Netherlands.
    Okma KG; Marmor TR; Oberlander J
    N Engl J Med; 2011 Jul; 365(4):287-9. PubMed ID: 21675914
    [No Abstract]   [Full Text] [Related]  

  • 2. Reforming Medicare by reforming incentives.
    Enthoven AC
    N Engl J Med; 2011 May; 364(21):e44. PubMed ID: 21561341
    [No Abstract]   [Full Text] [Related]  

  • 3. Can private Medicare health plans effectively compete with the government?
    Twiss AK
    Manag Care Interface; 2004 May; 17(5):25-6, 32. PubMed ID: 15217161
    [No Abstract]   [Full Text] [Related]  

  • 4. Payment reform--the need to harmonize approaches in Medicare and the private sector.
    Lee PV; Berenson RA; Tooker J
    N Engl J Med; 2010 Jan; 362(1):3-5. PubMed ID: 20007550
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond the "R word"? Medicine's new frugality.
    Bloche MG
    N Engl J Med; 2012 May; 366(21):1951-3. PubMed ID: 22551108
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bending the cost curve through market-based incentives.
    Antos JR; Pauly MV; Wilensky GR
    N Engl J Med; 2012 Sep; 367(10):954-8. PubMed ID: 22852881
    [No Abstract]   [Full Text] [Related]  

  • 8. US health spending accelerated in 1998.
    Charatan F
    BMJ; 2000 Jan; 320(7229):203. PubMed ID: 10642209
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare versus private insurance: in Texas, variations on a theme.
    Franzini L; Mikhail OI
    Health Aff (Millwood); 2010 Dec; 29(12):2310. PubMed ID: 21134934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare reform. Will the train stay on track ... or even leave the station?
    Wagner L; Hawryluk M
    Provider; 1995 Aug; 21(8):58-64, 67-9. PubMed ID: 10144818
    [No Abstract]   [Full Text] [Related]  

  • 11. Managed competition in The Netherlands: lessons from five years of health care reform.
    van de Ven W; Rutten F
    Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Justifying government as the backstop in health insurance markets.
    Swartz K
    Yale J Health Policy Law Ethics; 2001; 2(1):89-108. PubMed ID: 12664938
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of government in health care: a societal issue.
    DeBakey ME
    Am J Surg; 2006 Feb; 191(2):145-57. PubMed ID: 16442936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More dollars for doctors?
    Pretzer M
    Med Econ; 1998 Nov; 75(23):38, 41. PubMed ID: 10187679
    [No Abstract]   [Full Text] [Related]  

  • 15. Everybody into the pool! Medicare in the twenty-first century.
    Poplin C
    J Health Soc Policy; 1997; 9(2):49-60. PubMed ID: 10174378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care spending: can the United States control it?
    Altman SH; Wallack SS
    Baxter Health Policy Rev; 1996; 2():1-32. PubMed ID: 11066257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the cost of insurance reflect the cost of use in local hospital markets?
    Wennberg JE
    N Engl J Med; 1982 Nov; 307(22):1374-81. PubMed ID: 6813738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marketing Medicare. Legislation would force federal program to compete with private sector.
    Benko LB
    Mod Healthc; 2003 Dec 22-29; 33(51):30-3. PubMed ID: 14723087
    [No Abstract]   [Full Text] [Related]  

  • 19. Part "D" for "defective"--the Medicare drug-benefit chaos.
    Avorn J
    N Engl J Med; 2006 Mar; 354(13):1339-41. PubMed ID: 16571877
    [No Abstract]   [Full Text] [Related]  

  • 20. When money is the mission--the high costs of investor-owned care.
    Woolhandler S; Himmelstein DU
    N Engl J Med; 1999 Aug; 341(6):444-6. PubMed ID: 10432332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.